Yeji
PDUFAconf 0.75

olezarsen — PDUFA

$IONS · IONIS PHARMACEUTICALS INC · Familial chylomicronemia syndrome (FCS)
Event date
Date TBD
Sponsor runway
7 mo
$1.92B liquid

Evidence

We are on track to submit a supplemental new drug application for both the 50 mg and 80 mg doses to the U.S. Food and Drug Administration ("FDA") by the end of the year and expect a Prescription Drug User Fee Act ("PDUFA") target action date in 2026.
Source: 8-K filed 2025-11-10View on EDGAR ↗0001140361-25-041225

Comparable historical pdufas· last 5 years · same indication

TickerDrugDateOutcome
$IONSolezarsen2024-12-19unknown

Recent insider activity· ±90 days

4 insiders · 0 buys · 7 sells
Exercise10b5-1
2026-05-14
Monia Brett P
Chief Executive Officer
3,220 @ $32.60$105K
Sell10b5-1
2026-05-14
Monia Brett P
Chief Executive Officer
3,220 @ $78.68$253K
Exercise10b5-1
2026-05-13
Monia Brett P
Chief Executive Officer
1,316 @ $32.60$43K
Sell10b5-1
2026-05-13
Monia Brett P
Chief Executive Officer
1,316 @ $78.01$103K
Sell10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
17,781 @ $75.58$1.34M
Exercise10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
12,000 @ $40.05$481K
Exercise10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
10,321 @ $41.08$424K
Exercise10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
16,000 @ $42.88$686K
Sell10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
59,508 @ $74.90$4.46M
Exercise10b5-1
2026-05-04
LOSCALZO JOSEPH
Director
10,968 @ $38.06$417K
Sell10b5-1
2026-05-01
KLEIN JOSEPH III
Director
8,680 @ $73.35$637K
Sell10b5-1
2026-05-01
KLEIN JOSEPH III
Director
1,431 @ $74.45$107K
Exercise10b5-1
2026-05-01
KLEIN JOSEPH III
Director
10,111 @ $47.11$476K
Sell10b5-1
2026-04-28
Baroldi Joseph
EVP, Chief Business Officer
1,626 @ $71.79$117K